Psychedelics in Psychiatry, Volume 181, the latest release in the International Review of Neurobiology series, highlights new advances in the field, with this new volume presenting interesting chapters written by an international board of authors. Chapters in this new volume include History of psychedelic drug science and molecular pharmacology, Pharmacological mechanisms and neuroplastic potential of non-psychedelic agents, Anti-inflammatory activity, Translational approaches for investigating the effects of psychedelics on cognitive and affective behaviors in rodents, Clinical pharmacology, Human neuroimaging fMRI, and more.
Other chapters in this new release include Effects of psychedelics on human oscillatory brain activity, Molecular neuroimaging of psychedelic drug effects, Neurobiology of sub-psychedelic doses, Depression and related disorders, Addictions, Trauma disorders, Neurological disorders, and Challenges to the developing field of psychedelic medicine - political and ethical considerations and commercialization of therapy.
1. Cover image - p. i 2. Title page - p. ii 3. Table of Contents - p. iii 4. Series Page - p. iii 5. Copyright - p. iv 6. Contributors - p. xiii 7. Preface - p. xvii 8. Foreword - p. xix 9. Chapter One: History of psychedelic drug science and molecular pharmacology - p. 3 10. Chapter Two: Serotonin, immune function, and psychedelics as potent anti-inflammatories - p. 45 11. Chapter Three: Cognitive and affective models of psychedelics in rodents - p. 77 12. Chapter Four: Clinical pharmacology - p. 99 13. Chapter Five: Human neuroimaging: fMRI - p. 149 14. Chapter Six: Effects of psychedelics on human oscillatory brain activity - p. 171 15. Chapter Seven: Molecular brain imaging of psychedelic action - p. 203 16. Chapter Eight: Potential therapeutic effects of psychedelics in small doses: Is there a role for microdosing in psychiatry? - p. 231 17. Chapter Nine: Serotonergic psychedelics for depression: A comprehensive overview - p. 271 18. Chapter Ten: Psychedelics and substance use disorder treatment - p. 305 19. Chapter Eleven: Post-traumatic stress disorder in psychedelic research - p. 329 20. Chapter Twelve: Psychedelics for the treatment of end-of-life distress in patients with a life-threatening disease - p. 357 21. Chapter Thirteen: The protective effect of DMT against neurodegeneration - p. 395
Psychedelics in Psychiatry, Volume 181, the latest release in the International Review of Neurobiology series, highlights new advances in the field, with this new volume presenting interesting chapters written by an international board of authors. Chapters in this new volume include History of psychedelic drug science and molecular pharmacology, Pharmacological mechanisms and neuroplastic potential of non-psychedelic agents, Anti-inflammatory activity, Translational approaches for investigating the effects of psychedelics on cognitive and affective behaviors in rodents, Clinical pharmacology, Human neuroimaging fMRI, and more.
Other chapters in this new release include Effects of psychedelics on human oscillatory brain activity, Molecular neuroimaging of psychedelic drug effects, Neurobiology of sub-psychedelic doses, Depression and related disorders, Addictions, Trauma disorders, Neurological disorders, and Challenges to the developing field of psychedelic medicine - political and ethical considerations and commercialization of therapy.
1. Cover image - p. i 2. Title page - p. ii 3. Table of Contents - p. iii 4. Series Page - p. iii 5. Copyright - p. iv 6. Contributors - p. xiii 7. Preface - p. xvii 8. Foreword - p. xix 9. Chapter One: History of psychedelic drug science and molecular pharmacology - p. 3 10. Chapter Two: Serotonin, immune function, and psychedelics as potent anti-inflammatories - p. 45 11. Chapter Three: Cognitive and affective models of psychedelics in rodents - p. 77 12. Chapter Four: Clinical pharmacology - p. 99 13. Chapter Five: Human neuroimaging: fMRI - p. 149 14. Chapter Six: Effects of psychedelics on human oscillatory brain activity - p. 171 15. Chapter Seven: Molecular brain imaging of psychedelic action - p. 203 16. Chapter Eight: Potential therapeutic effects of psychedelics in small doses: Is there a role for microdosing in psychiatry? - p. 231 17. Chapter Nine: Serotonergic psychedelics for depression: A comprehensive overview - p. 271 18. Chapter Ten: Psychedelics and substance use disorder treatment - p. 305 19. Chapter Eleven: Post-traumatic stress disorder in psychedelic research - p. 329 20. Chapter Twelve: Psychedelics for the treatment of end-of-life distress in patients with a life-threatening disease - p. 357 21. Chapter Thirteen: The protective effect of DMT against neurodegeneration - p. 395
